BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 8657727)

  • 1. Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma.
    Wilkens L; Flemming P; Gebel M; Bleck J; Terkamp C; Wingen L; Kreipe H; Schlegelberger B
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1309-14. PubMed ID: 14745031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of PACAP activity by a receptor antagonist results in changes in cell cycle and apoptotic proteins in chick neuroblasts.
    Erhardt NM; Haines LR; Pearson TW; Sherwood NM
    J Mol Neurosci; 2005; 27(1):107-23. PubMed ID: 16055950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients.
    Bahnassy AA; Zekri AR; El-Houssini S; El-Shehaby AM; Mahmoud MR; Abdallah S; El-Serafi M
    BMC Gastroenterol; 2004 Sep; 4():22. PubMed ID: 15385053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H3 mRNA in situ hybridization for identifying proliferating cells in human pancreas, with special reference to the ductal system.
    Arakura N; Hayama M; Honda T; Matsuzawa K; Akamatsu T; Ota H
    Histochem J; 2001 Mar; 33(3):183-91. PubMed ID: 11508342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of histone H3 messenger RNA in situ hybridization for the assessment of cell proliferation in human tissues.
    Kotelnikov V; Cass L; Coon JS; Spaulding D; Preisler HD
    Clin Cancer Res; 1997 May; 3(5):669-73. PubMed ID: 9815735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone H3 messenger RNA in situ hybridization correlates with in vivo bromodeoxyuridine labeling of S-phase cells in rat colonic epithelium.
    Konishi H; Steinbach G; Terry NH; Lee JJ; Dubin JA; Glober GA; Fujita K; Spaulding D; Cass L; Hittelman WN
    Cancer Res; 1996 Feb; 56(3):434-7. PubMed ID: 8564947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S phase determination in intact colonic crypts by histone H3 messenger RNA in situ hybridization and confocal microscopy.
    Konishi H; Steinbach G; Terry NH; Fujita K; Lee JJ; Ruifrok A; Spaulding D; Lynch PM; Dubin JA; Andreeff M; Goodacre AM; Hattori T; Hittelman WN
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):531-6. PubMed ID: 9232341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic analyses of hepatocellular carcinoma by in situ hybridization with a chromosome-specific DNA probe.
    Kimura H; Kagawa K; Deguchi T; Nakajima T; Kakusui M; Ohkawara T; Katagishi T; Okanoue T; Kashima K; Ashihara T
    Cancer; 1996 Jan; 77(2):271-7. PubMed ID: 8625234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA fragmentation and cell proliferation correlated with tumor grade in patients with hepatocellular carcinoma.
    Kalogeraki A; Garbagnati F; Santinami M; Zoras O
    Cancer; 2002 Oct; 96(5):301-5. PubMed ID: 12378598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histologic grade and other cell proliferative markers.
    Nagao T; Ishida Y; Kondo Y
    Mod Pathol; 1996 Feb; 9(2):99-104. PubMed ID: 8657727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histochemical localization of cell proliferation using in situ hybridization for histone mRNA.
    Hewitson TD; Kelynack KJ; Darby IA
    Methods Mol Biol; 2006; 326():219-26. PubMed ID: 16780204
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.